News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Inc. (ESALF.PK) CEO Sees "Huge" Medical Need for New Diet Drug


8/15/2012 6:53:15 AM

Japan's Eisai Co. (ESALY, 4523.TO) will target a "huge unmet medical need" with its plan to begin selling the new diet drug Belviq in the U.S. in early 2013, the company's leader said Tuesday. Chief Executive Haruo Naito said Eisai will market the drug by aiming to enhance disease awareness, collaborate with patient groups and seek insurance coverage of Belviq. Obesity is "obviously a huge unmet medical need in this country," Mr. Naito said in an interview Tuesday. "It's a major medical expenditure and social cost."



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES